While second-hit loss of function mutations in VHL are present in over 90% of ccRCC, complete loss of VHL expression alone is insufficient to produce ccRCC in humans as well as mice (27, 28). The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.